OTC Markets OTCPK - Delayed Quote USD

Finch Therapeutics Group, Inc. (FNCH)

Compare
11.00 +0.64 (+6.56%)
At close: December 20 at 3:44:12 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
107.00
861.00
18,532.00
7,719.00
Gross Profit
--
--
--
--
7,719.00
Operating Expense
19,689.00
34,109.00
89,055.00
78,517.00
47,155.00
Operating Income
-19,689.00
-34,002.00
-88,194.00
-59,985.00
-39,436.00
Net Non Operating Interest Income Expense
1,232.00
1,570.00
252.00
22.00
106.00
Other Income Expense
4,290.00
-45,783.00
-26,704.00
1,803.00
-11.00
Pretax Income
-14,167.00
-78,215.00
-114,646.00
-58,160.00
-39,341.00
Tax Provision
--
-3,461.00
--
--
--
Net Income Common Stockholders
-14,167.00
-74,754.00
-114,646.00
-58,160.00
-39,341.00
Diluted NI Available to Com Stockholders
-14,167.00
-74,754.00
-114,646.00
-58,160.00
-39,341.00
Basic EPS
-8.80
-46.59
-72.00
-44.40
-25.72
Diluted EPS
-8.80
-46.59
-72.00
-44.40
-25.72
Basic Average Shares
1,605.53
1,604.55
1,589.72
1,306.74
1,529.85
Diluted Average Shares
1,605.53
1,604.55
1,589.72
1,306.74
1,529.85
Total Operating Income as Reported
-19,504.00
-83,861.00
-115,593.00
-59,985.00
-39,436.00
Total Expenses
19,689.00
34,109.00
89,055.00
78,517.00
47,155.00
Net Income from Continuing & Discontinued Operation
-14,167.00
-74,754.00
-114,646.00
-58,160.00
-39,341.00
Normalized Income
-14,372.00
-27,130.72
-87,240.00
-60,015.00
-39,328.00
Interest Income
--
1,570.00
252.00
22.00
106.00
Net Interest Income
1,232.00
1,570.00
252.00
22.00
106.00
EBIT
-19,689.00
-34,002.00
-88,194.00
-59,985.00
-39,436.00
EBITDA
-19,506.00
-32,482.00
-82,687.00
-57,684.00
-38,646.00
Reconciled Depreciation
183.00
1,520.00
5,507.00
2,301.00
790.00
Net Income from Continuing Operation Net Minority Interest
-14,167.00
-74,754.00
-114,646.00
-58,160.00
-39,341.00
Total Unusual Items Excluding Goodwill
205.00
-49,836.00
-27,406.00
1,855.00
-13.00
Total Unusual Items
205.00
-49,836.00
-27,406.00
1,855.00
-13.00
Normalized EBITDA
-19,711.00
17,354.00
-55,281.00
-59,539.00
-38,633.00
Tax Rate for Calcs
--
0.00
--
--
--
Tax Effect of Unusual Items
--
-2,212.72
--
--
--
12/31/2020 - 3/19/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IKNA Ikena Oncology, Inc.
1.5500
-3.73%
 
G28.F Tevogen Bio Holdings Inc.
0.8700
+2.35%
 
CNTB Connect Biopharma Holdings Limited
0.9509
-2.97%
 
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
 
VVY.AS Vivoryon Therapeutics N.V.
1.9720
+0.61%
 
ADAG Adagene Inc.
2.0500
+2.50%
 
ARTH Arch Therapeutics, Inc.
0.2571
-12.85%
 
TYRA Tyra Biosciences, Inc.
14.00
-3.45%
 
AVTE Aerovate Therapeutics, Inc.
2.5300
0.00%
 
VBIVQ VBI Vaccines Inc.
0.0005
0.00%